Skip to Main Content

Paper Details

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells.
Beilstein J Nanotechnol
25
2019
Author NameAffiliation
Mark N WassUniversity of Kent
  • 1 - 1

Datasets

Release 1.2